Can You Buy Mounjaro Over the Counter? Legal Routes and Prices

No. Mounjaro needs a prescription in the US, and no GLP-1 is sold over the counter.

Prescription: RequiredFDA label (DailyMed)
Telehealth from, all in: $2,048 a month
Shortage: Resolved

A quick look at Mounjaro

How long the body keeps it

About 5 days is the half-life. After 5 d, half has gone; about 3% remains after five half-lives (25 d).

Weight loss in the main trial

In the 40-week SURPASS-1 study for type 2 diabetes, people lost 7.8 kg, compared with 1 kg in the placebo group.

Price as time goes by

Monthly prices in US dollars cover list price and self-pay offers, with each figure read from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, pricinginfo.lilly.com.

All legit routes to Mounjaro, ranked

Options ordered by lowest cost
Route	Who it is for	What you pay
Your doctor, with insurance and the savings card	Commercial insurance that covers it	A fill of up to 3 months may cost as little as $25
Telehealth: Hims & Hers, Mounjaro	Online visit, medicine shipped	$2,048 a month all in

Prices checked November 2026. Each listed price links to its source page.

Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, FDA.

Who can qualify

In the US, every GLP-1 medicine requires a prescription. A prescriber writes it when the use is approved on the label:

Used with diet and exercise, it lowers blood sugar for adults and children aged 10 and older who have type 2 diabetes.
A heart attack, stroke, or death linked to the heart becomes less likely when high-risk adults who have type 2 diabetes take it.

Source: FDA label (DailyMed).

Comparing telehealth options

Mounjaro telehealth options
Program	Medicine option	Medicine price	Membership	All in
Hims & Hers	Mounjaro	$1,899 a month	$149 a month after first month	$2,048 a month

Each program's own pricing page supplies the prices. We do not get money from any of them.

Source: hims.com.

Shortage update

The Tirzepatide Shortage has been resolved. Confirmation came from FDA on December 19, 2024.

It first appeared on the FDA shortage list on December 15, 2022
Shortage resolved: December 19, 2024
From February 18, 2025, state pharmacies had to stop compounding copies
On March 19, 2025, outsourcing facilities had to stop

Source: FDA.

Signs of a scam

No prescription needed: the seller is not a licensed US pharmacy if it skips the prescription.
Sold as the brand but compounded: the FDA has not approved compounded drugs, and none of them is Ozempic, Wegovy, Mounjaro or Zepbound.
Telehealth companies claiming compounded drugs are the same as the brand received 30 warning letters from the FDA over misleading claims.
Harm reports: FDA records more than 730 adverse event reports for compounded tirzepatide.
The drug is missing from the monthly price: the FTC took action against one program for this; see NextMed review.

Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, FDA.

Look it up in your state

Hims & Hers: some of the 50 states are not served
Noom Med: some of the 50 states are not served
NovoCare Pharmacy: Its delivery network reaches 50 states plus DC, Puerto Rico

Rules in Medicaid programs affect the route more than any other factor. Medicaid programs in 10 states cover GLP-1s for weight loss right now. Choose your state to see its drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.